Pancreatic Cancer Research

ResearcherShanghai Medical College of Fudan UniversityNo recent work listed

Zhibo Xie

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0002-5067-4375; OpenAlex author ID A5103269862. Sources: OpenAlex.

Their work

Papers
8 (first author 1, last author 0)
Trials
0
Grants
0
Labs led
0
Collaborators
13
Papers, trials and grants by year

2016: 1 paper · 2017: 1 paper · 2018: none · 2019: 3 papers · 2020: 2 papers · 2021: none · 2022: 1 paper

Papers 8

  1. Exosome-delivered CD44v6/C1QBP complex drives pancreatic cancer liver metastasis by promoting fibrotic liver microenvironment. Co-author DOI 10.1136/gutjnl-2020-323014↗
  2. Controlling Nutritional Status score is superior to Prognostic Nutritional Index score in predicting survival and complications in pancreatic ductal adenocarci… Co-author DOI 10.1017/s0007114520002299↗
  3. LyP-1-fMWNTs enhanced targeted delivery of MBD1siRNA to pancreatic cancer cells. First author DOI 10.1111/jcmm.14864↗
  4. High cytoplasm HABP1 expression as a predictor of poor survival and late tumor stage in pancreatic ductal adenocarcinoma patients. Co-author DOI 10.1016/j.ejso.2018.09.020↗
  5. LRG-1 promotes pancreatic cancer growth and metastasis via modulation of the EGFR/p38 signaling. Co-author DOI 10.1186/s13046-019-1088-0↗
  6. Pancreatoduodenectomy with portal vein resection favors the survival time of patients with pancreatic ductal adenocarcinoma: A propensity score matching analys… Co-author DOI 10.3892/ol.2019.10822↗
  7. Portal vein resection and reconstruction with artificial blood vessels is safe and feasible for pancreatic ductal adenocarcinoma patients with portal vein invo… Co-author DOI 10.18632/oncotarget.20847↗
  8. Circulating tumor cells in pancreatic cancer patients: efficacy in diagnosis and value in prognosis. Co-author PMID 27755967↗

Closest collaborators

The 13 strongest of 13 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Deliang Fu · 7 shared papers, 2016–2022 · strength 0.80
  2. Yifan Zhang · 5 shared papers, 2017–2022 · strength 0.59
  3. Chen Jin · 5 shared papers, 2016–2019 · strength 0.51
  4. Yishen Mao · 3 shared papers, 2019–2022 · strength 0.41
  5. Lie Yao · 4 shared papers, 2016–2020 · strength 0.41
  6. Jichun Gu · 2 shared papers, 2017–2019 · strength 0.18
  7. Sijie Hao · 1 shared paper, 2020 · strength 0.15
  8. Deliang Fu · 1 shared paper, 2020 · strength 0.13
  9. Quanjun Lin · 1 shared paper, 2020 · strength 0.13
  10. Ji Li · 1 shared paper, 2019 · strength 0.11
  11. Feng Yang · 1 shared paper, 2017 · strength 0.07
  12. Yongjian Jiang · 1 shared paper, 2017 · strength 0.07
  13. Ji Li · 1 shared paper, 2017 · strength 0.07

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.